J. A. Janssen

Identification of genes potentially involved in disease transformation of CML

Q. Waisfisz, G. Pasterkamp, G. Schuurhuis, 2005, Leukemia.

Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS

E. Vellenga, M. Jongen‐Lavrencic, L. Michaux, 2020, Leukemia.

CD40-targeted adenoviral GM-CSF gene transfer enhances and prolongs the maturation of human CML-derived dendritic cells upon cytokine deprivation

D. Curiel, T. D. de Gruijl, G. Ossenkoppele, 2003, British Journal of Cancer.

Vaccination of chronic myeloid leukemia patients with autologous in vitro cultured leukemic dendritic cells

G. Ossenkoppele, R. Scheper, A. A. van de Loosdrecht, 2003, Leukemia.

High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcome (vol 93, pg 1894, 2008)

G. Ossenkoppele, B. Löwenberg, M. Chamuleau, 2007 .

Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome

M. Jongen‐Lavrencic, M. Gregor, G. Ossenkoppele, 2022, Leukemia.

Secondary imatinib resistance associated with an aberrant bcr-abl fusion gene

Q. Waisfisz, G. Schuurhuis, J. Janssen, 2004, Leukemia.